Russia to Start the Production of Its COVID-19 Vaccine in Cuba

Before being tested in 76 volunteers, the "Sputnik V" passed all the safety and efficacy tests.

By Telesur
Global Research, August 14, 2020
teleSUR 11 August 2020
Region: ,
Theme:

Russia’s Direct Investment Fund (RDIF) Chief Executive Officer Kiril Dmitriev announced that Cuba could begin producing the COVID-19 vaccine, the Sputnik V, in November.

“Cuba has a large capacity to produce medicines and vaccines with highly qualified staff. We could coordinate with its government to start the vaccine production in November,” Dmitriev stated.

He also pointed out that the third stage of vaccine trials will begin in Russia on Wednesday. Later the United Arab Emirates, Saudi Arabia, and the Philippines will continue testing it.

On Tuesday, Health Minister Mikhail Murashko announced the registration of the world’s first COVID-19 vaccine, the Sputnik V, which is named after the first artificial satellite launched into orbit by the USSR in 1957.

Before being tested in 76 volunteers, the Russian COVID-19 vaccine passed all the necessary safety and efficacy tests in several animal species.

On Tuesday morning, outlet Sputnik reported that that the Russian vaccine, which was developed by the Gamaleya Research Institute, can protect a person from the coronavirus for up to two years after injection.

“Such a prolonged period of protection is possible due to the vaccine being based on viral vectors – a harmless human adenovirus delivers a portion of the COVID-19 virus to a human body forcing it to form an immune response to it,” the Russian outlet explained.

*

Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image: BioCubaFarma facilities in Cuba, August, 2020. | Photo: Twitter/ @CubaStandard
Articles by: Telesur

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]